JMJD4 抗体 (C-Term)
Quick Overview for JMJD4 抗体 (C-Term) (ABIN2781196)
抗原
适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- C-Term
-
序列
- AAFDVGRITE VLASLVAHPD FQRVDTSAFS PQPKELLQQL REAVDAAAAP
-
预测反应
- Human: 100%, Mouse: 91%, Pig: 91%, Rat: 91%
-
产品特性
- This is a rabbit polyclonal antibody against JMJD4. It was validated on Western Blot using a cell lysate as a positive control.
-
纯化方法
- Affinity Purified
-
免疫原
- The immunogen is a synthetic peptide directed towards the C terminal region of human JMJD4
-
-
anti-Jumonji Domain Containing 4 (JMJD4) (AA 72-121) antibody
JMJD4 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Jumonji Domain Containing 4 (JMJD4) (C-Term) antibodyJMJD4 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Jumonji Domain Containing 4 (JMJD4) (AA 1-463) antibodyJMJD4 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Jumonji Domain Containing 4 (JMJD4) (AA 423-455), (C-Term) antibodyJMJD4 适用: 人, 小鼠 WB, IHC (p) 宿主: 兔 Polyclonal RB10802 unconjugated
anti-Jumonji Domain Containing 4 (JMJD4) (C-Term) antibodyJMJD4 适用: 人, 小鼠, 大鼠, Pig, Cow, 犬, 豚鼠, 马, 兔 WB 宿主: 兔 Polyclonal unconjugated
anti-Jumonji Domain Containing 4 (JMJD4) (AA 1-30) antibodyJMJD4 适用: 人 WB, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Jumonji Domain Containing 4 (JMJD4) (N-Term) antibodyJMJD4 适用: 人, 大鼠 WB, IHC (p), EIA 宿主: 兔 Polyclonal unconjugated
anti-Jumonji Domain Containing 4 (JMJD4) (C-Term) antibodyJMJD4 适用: 人, 小鼠 WB, EIA 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilutions should be determined experimentally by the investigator.
-
说明
-
Antigen size: 463 AA
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- Lot specific
-
缓冲液
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freeze-thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
-
